» Articles » PMID: 35650220

Anabolic-androgenic Steroid Use is Associated with Psychopathy, Risk-taking, Anger, and Physical Problems

Overview
Journal Sci Rep
Specialty Science
Date 2022 Jun 1
PMID 35650220
Authors
Affiliations
Soon will be listed here.
Abstract

Previous research has uncovered medical and psychological effects of anabolic-androgenic steroid (AAS) use, but the specific relationship between AAS use and risk-taking behaviors as well as between AAS use and psychopathic tendencies remains understudied. To explore these potential relationships, we anonymously recruited 492 biologically male, self-identified bodybuilders (median age 22; range 18-47 years) from online bodybuilding fora to complete an online survey on Appearance and Performance Enhancing Drug (APED) use, psychological traits, lifestyle choices, and health behaviors. We computed odds ratios and 95% confidence intervals using logistic regression, adjusting for age, race, education, exercise frequency, caloric intake, and lean BMI. Bodybuilders with a prior history of AAS use exhibited heightened odds of psychopathic traits, sexual and substance use risk-taking behaviors, anger problems, and physical problems compared to those with no prior history of AAS use. This study is among the first to directly assess psychopathy within AAS users. Our results on risk-taking, anger problems, and physical problems are consistent with prior AAS research as well as with existing frameworks of AAS use as a risk behavior. Future research should focus on ascertaining causality, specifically whether psychopathy is a risk associated with or a result of AAS use.

Citing Articles

Relationship Between Anabolic-Androgenic Steroid Use, Aggression, and Narcissism in Male Bodybuilders.

Ceto E, Yigitoglu P, Yavuz H Medicina (Kaunas). 2025; 61(2).

PMID: 40005358 PMC: 11857202. DOI: 10.3390/medicina61020241.


Differentiation of adsorption and degradation in steroid hormone micropollutants removal using electrochemical carbon nanotube membrane.

Liu S, Jassby D, Mandler D, Schafer A Nat Commun. 2024; 15(1):9524.

PMID: 39496594 PMC: 11535516. DOI: 10.1038/s41467-024-52730-7.


Exploring Anabolic Androgenic Steroid Use Among Cisgender Gay, Bisexual, and Queer Men.

Kutscher E, Arshed A, Greene R, Kladney M JAMA Netw Open. 2024; 7(5):e2411088.

PMID: 38743422 PMC: 11094559. DOI: 10.1001/jamanetworkopen.2024.11088.


Impact of androgenic anabolic steroid use on cardiovascular and mental health in Danish recreational athletes: protocol for a nationwide cross-sectional cohort study as a part of the Fitness Doping in Denmark (FIDO-DK) study.

Buhl L, Christensen L, Diederichsen A, Lindholt J, Kistorp C, Glintborg D BMJ Open. 2024; 14(5):e078558.

PMID: 38719280 PMC: 11086435. DOI: 10.1136/bmjopen-2023-078558.


Performance-enhancing substances in sport: A scientometric review of 75 years of research.

Carollo A, Corazza O, Mantovani M, Silvestrini N, Rabin O, Esposito G Drug Test Anal. 2024; 17(1):13-24.

PMID: 38491903 PMC: 11730354. DOI: 10.1002/dta.3677.


References
1.
Neumann C, Hare R . Psychopathic traits in a large community sample: links to violence, alcohol use, and intelligence. J Consult Clin Psychol. 2008; 76(5):893-9. DOI: 10.1037/0022-006X.76.5.893. View

2.
Kanayama G, Kean J, Hudson J, Pope Jr H . Cognitive deficits in long-term anabolic-androgenic steroid users. Drug Alcohol Depend. 2012; 130(1-3):208-14. PMC: 3608708. DOI: 10.1016/j.drugalcdep.2012.11.008. View

3.
Hauger L, Havnes I, Jorstad M, Bjornebekk A . Anabolic androgenic steroids, antisocial personality traits, aggression and violence. Drug Alcohol Depend. 2021; 221:108604. DOI: 10.1016/j.drugalcdep.2021.108604. View

4.
Corrigan B . Anabolic steroids and the mind. Med J Aust. 1996; 165(4):222-6. DOI: 10.5694/j.1326-5377.1996.tb124932.x. View

5.
Spitzer R, Kroenke K, Williams J, Lowe B . A brief measure for assessing generalized anxiety disorder: the GAD-7. Arch Intern Med. 2006; 166(10):1092-7. DOI: 10.1001/archinte.166.10.1092. View